Akari Therapeutics (AKTX)
NASDAQ: AKTX
· Real-Time Price · USD
0.71
-0.02 (-2.74%)
At close: Sep 04, 2025, 3:57 PM
Akari Therapeutics Stock Forecast
Stock Price Forecast
The 1 analysts with 12-month price forecasts for AKTX stock have an median target of 5, with a low estimate of 5 and a high estimate of 5. The median target predicts an increase of 604.23% from the current stock price of 0.71.
| Target | Low | Average | Median | High |
|---|---|---|---|---|
| Price | 5 | 5 | 5 | 5 |
| Change | 604.23% | 604.23% | 604.23% | 604.23% |
Latest Analyst Insight Report
According to 1 stock analyst, the rating for Akari Therapeutics is "Buy". This means that the analyst believes this stock is likely to lead to higher returns than market as a whole.
| Rating | Jul 25 |
|---|---|
| Strong Buy | 0 |
| Buy | 1 |
| Hold | 0 |
| Sell | 0 |
| Strong Sell | 0 |
| Total | 1 |
Financial Forecast this Year
Revenue This Year
3.54M
from 0
Increased by n/a%
Revenue Next Year
9.58M
from 3.54M
Increased by 170.6%
EPS This Year
-0.45
from -1660
Increased by 100.0%
EPS Next Year
-0.46
from -0.45
Increased by -2.2%